Vagia Patsoukaki
Statistiker PhD vid Institutionen för medicinska vetenskaper; Klinisk diabetologi och metabolism
- Telefon:
- 018-617 24 71, 076-708 65 24
- E-post:
- vagia.patsoukaki@medsci.uu.se
- Besöksadress:
- Akademiska sjukhuset, ingång 40, 5 tr
751 85 UPPSALA - Postadress:
- Akademiska sjukhuset, ingång 40, 5 tr
751 85 Uppsala
Publikationer
Senaste publikationer
-
Ingår i Diabetes, obesity and metabolism, s. 1327-1338, 2026
- DOI för SGLT2 inhibitor or metformin as standard treatment in early-stage type 2 diabetes? Baseline data in SMARTEST, a novel, decentralised, register-based randomised trial on prevention of diabetic complications
- Ladda ner fulltext (pdf) av SGLT2 inhibitor or metformin as standard treatment in early-stage type 2 diabetes? Baseline data in SMARTEST, a novel, decentralised, register-based randomised trial on prevention of diabetic complications
-
Ingår i Journal of Clinical Endocrinology and Metabolism, 2025
- DOI för Altered Expression of Aromatase and Estrogen Receptors in Adipose Tissue From Men With Obesity or Type 2 Diabetes
- Ladda ner fulltext (pdf) av Altered Expression of Aromatase and Estrogen Receptors in Adipose Tissue From Men With Obesity or Type 2 Diabetes
-
Ingår i The Lancet Diabetes and Endocrinology, s. 848-862, 2025
-
Ingår i Diabetes & Vascular Disease Research, 2023
- DOI för Health care registers can be instrumental for endpoint capture in clinical diabetes trials: example of microvascular complications in Swedish patients with type 2 diabetes
- Ladda ner fulltext (pdf) av Health care registers can be instrumental for endpoint capture in clinical diabetes trials: example of microvascular complications in Swedish patients with type 2 diabetes
-
Ingår i Endocrinology, 2023
- DOI för Increased OCT3 Expression in Adipose Tissue With Aging: Implications for Catecholamine and Lipid Turnover and Insulin Resistance in Women
- Ladda ner fulltext (pdf) av Increased OCT3 Expression in Adipose Tissue With Aging: Implications for Catecholamine and Lipid Turnover and Insulin Resistance in Women
Alla publikationer
Artiklar i tidskrift
-
Ingår i Diabetes, obesity and metabolism, s. 1327-1338, 2026
- DOI för SGLT2 inhibitor or metformin as standard treatment in early-stage type 2 diabetes? Baseline data in SMARTEST, a novel, decentralised, register-based randomised trial on prevention of diabetic complications
- Ladda ner fulltext (pdf) av SGLT2 inhibitor or metformin as standard treatment in early-stage type 2 diabetes? Baseline data in SMARTEST, a novel, decentralised, register-based randomised trial on prevention of diabetic complications
-
Ingår i Journal of Clinical Endocrinology and Metabolism, 2025
- DOI för Altered Expression of Aromatase and Estrogen Receptors in Adipose Tissue From Men With Obesity or Type 2 Diabetes
- Ladda ner fulltext (pdf) av Altered Expression of Aromatase and Estrogen Receptors in Adipose Tissue From Men With Obesity or Type 2 Diabetes
-
Ingår i The Lancet Diabetes and Endocrinology, s. 848-862, 2025
-
Ingår i Diabetes & Vascular Disease Research, 2023
- DOI för Health care registers can be instrumental for endpoint capture in clinical diabetes trials: example of microvascular complications in Swedish patients with type 2 diabetes
- Ladda ner fulltext (pdf) av Health care registers can be instrumental for endpoint capture in clinical diabetes trials: example of microvascular complications in Swedish patients with type 2 diabetes
-
Ingår i Endocrinology, 2023
- DOI för Increased OCT3 Expression in Adipose Tissue With Aging: Implications for Catecholamine and Lipid Turnover and Insulin Resistance in Women
- Ladda ner fulltext (pdf) av Increased OCT3 Expression in Adipose Tissue With Aging: Implications for Catecholamine and Lipid Turnover and Insulin Resistance in Women